Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: Further lessons from Iraqi-Jewish Glanzmann thrombasthenia

Blood

Volumn 98, Issue 4, 2001, Pages 1063-1069

  Yatuv, Rivka ^a,b   Rosenberg, Nurit ^a,b   Zivelin, Ariella ^a,b   Peretz, Hava ^a,b   Dardik, Rima ^a,b   Trakhtenbrot, Luba ^a,b   Seligsohn, Uri ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PROTEIN SUBUNIT;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CHO CELL; COMPLEX FORMATION; DISULFIDE BOND; ENDOPLASMIC RETICULUM; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; GLANZMANN DISEASE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; JEW; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; STOP CODON;

EID: 0035883072     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.1063     Document Type: Article

References (20)

1. French DL, Seligsohn U. Platelet glycoprotein IIb/IIIa receptors and Glanzmann thrombasthenia. Arterioscler Thromb Vasc Biol. 2000;20:607-610.
2. Duperray A, Berthier R, Chagnon E, et al. Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes. J Cell Biol. 1987;104:1665-1673.
3. Duperray A, Trosch A, Berthier R, et al. Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between Pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface. Blood. 1989;74:1603-1611.
4. Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann thrombasthenia: new insight from an historical perspective. Semin Hematol. 1994;31:301-311.
5. French DL. Glanzmann Thrombasthenia Database. Mount Sinai School of Medicine Web site. Available at: http://med.mssm. edu/glanzmanndb. Accessed June 1, 1999.
6. Seligsohn U, Rososhansky S. A Glanzmann thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost. 1984;52:230-231.
7. Rosenberg N, Yatuv R, Orion Y, et al. Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (β3) is a second mutation in Iraqi Jews that stemmed from a distinct founder. Blood. 1997;89:3654-3662.
8. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab population in Israel. Proc Natl Acad Sci U S A. 1991;88:3160-3164.
9. Wang R, Peterson J, Aster RH, Newman PJ. Disruption of a long-range disulfide bond between residues Cys406 and Cys655 in glycoprotein IIIa does not affect the function of platelet glycoprotein IIb-IIIa [letter]. Blood. 1997;90:1718.
10. Dardik R, Kaufman Y, Savion N, Rosenberg N, Shenkman B, Varon D. Platelets mediate tumor cell adhesion to subendothelium under flow conditions: involvement of platelets GPIIb-IIIa and tumor cell αv integrins. Int J Cancer. 1997;70:201-207.
11. Ho N, Hunt H, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989;77:51-59.
12. Jackson DE, White MM, Jennings LK, Newman PJ. A Ser 162→Leu mutation within glycoprotein (GP) IIIa (integrin β3) results in an unstable αIIbβ3 complex that retains partial function in a novel form type II Glanzmann thrombasthenia. Thromb Haemost. 1998;80:42-48.
13. Kieffer N, Melchior C, Guinet JM, Michels S, Gouon V, Bron N. Serine 752 in the cytoplasmic domain of the β3 postreceptor signaling events. Cell Adhes Commun. 1996;4:25-39.
14. Morel-Kopp MC, Kaplan C, Proulle V, et al. A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann's thrombasthenia: importance of residues IIe325Pro326Gly327 for β3 integrin subunit association. Blood. 1997;90:669-677.
15. Frachet P, Duperray A, Delachanal E, Marguerie G. Role of the transmembrane and cytoplasmic domains in the assembly and surface exposure of the platelet integrin GPIIb/IIIa. Biochemistry. 1992;31:2408-2415.
16. Bennet JS, Kolodziej MA, Vilaire G, Poncz M. Determinants of the intracellular fate of truncated forms of the platelet glycoproteins IIb and IIIa. J Biol Chem. 1993;268:3580-3585.
17. Gulino D, Martinez P, Delachanal E, et al. Expression and purification of a soluble functional form of the platelet αIIbβ3 integrin. Eur J Biochem. 1995;227:108-115.
18. Liu CY, Sun QH, Wang R, Paddock CM, Newman PJ. Further examination of the role of GPIIIa longrange Cys5-Cys435 disulfide bond in conformational changes of GPIIb-IIIa: substitution of cysteine 5 with alanine results in the production of a constitutively active GPIIb-IIIa integrin complex [abstract]. Blood. 1998;92:344.
19. Coller BS, Seligsohn U, Zivelin A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the IraqiJewish and Arab populations in Israel: comparison of techniques for carrier detection. Br J Haematol. 1986;62:723-735.
20. Ferrer M, Tao J, Iruin G, et al. Truncation of glycoprotein (GP) IIIa (616-762) prevents complex formation with GPIIb: novel mutation in exon 11 of GPIIIa associated with thrombasthenia. Blood. 1998;92:4712-4720.